Boothbay Fund Management, LLC Bio Techne Corp Transaction History

Boothbay Fund Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$65.98 - $77.09 $738,448 - $862,791	-11,192 Reduced 40.16%	16,678 $1.17 Million
Q4 2023 Feb 14, 2024	BUY	$52.83 - $78.22 $1.02 Million - $1.51 Million	19,367 Added 227.77%	27,870 $2.15 Million
Q3 2023 Nov 14, 2023	BUY	$67.52 - $89.42 $574,122 - $760,338	8,503 New	8,503 $578,000
Q1 2023 May 15, 2023	SELL	$71.62 - $86.62 $179,336 - $216,896	-2,504 Reduced 46.87%	2,838 $210,000
Q4 2022 Feb 14, 2023	BUY	$80.67 - $352.29 $259,192 - $1.13 Million	3,213 Added 150.92%	5,342 $442,000
Q3 2022 Nov 14, 2022	BUY	$282.54 - $391.85 $601,527 - $834,248	2,129 New	2,129 $605,000
Q3 2021 Nov 15, 2021	SELL	$444.87 - $538.88 $205,974 - $249,501	-463 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$387.35 - $450.26 $179,343 - $208,470	463 New	463 $208,000

601

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.8B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.